Surveillance for the detection of recurrent ovarian cancer: Survival impact or lead-time bias?
复发性卵巢癌检测的监督：生存影响或是领先效应？
It can be used in the patients with recurrent ovarian cancer as a second or third line therapy.
尤其是对复发病人仍有效，可做为复发卵巢癌的二线或三线化疗。
The purpose of the study was to evaluate treatment opportunity for patients with recurrent ovarian cancer.
本研究目的是探讨复发性卵巢癌治疗的意义和方法。
Conclusions Maximum cytoreductive surgery is feasible and effective for advanced and recurrent ovarian cancer.
结论理想的肿瘤细胞减灭术对晚期及复发卵巢癌是安全可行的。
Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
用贝伐单抗治疗复发性卵巢上皮癌的患者中，哪种因素可以预测肠道并发症？
Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?
用贝伐单抗治疗复发性卵巢上皮癌的患者中，哪种因素可以预测肠道并发症？
应用推荐